VCREDIT Holdings Limited

All figures RMB million unless stated; FY = year ended 31 December; IFRS. Sources: FY2022 (FY2021/22), FY2023, FY2025 (FY2024/25) annual results announcements; H1 2026 interim announcement. Derived ratios are analyst calculations.

Income statement

Notes: "Gross profit" is not a meaningful concept for a credit platform; the "risk-adjusted income proxy" = total income − origination & servicing − credit impairment − fair value loss. EBITDA = operating profit + depreciation & amortisation + depreciation of right-of-use assets (FY2021 24.6+25.7; FY2022 28.0+25.8; FY2023 25.7+30.6; FY2024 31.0+30.7; FY2025 33.8+25.7); for a lender, interest expense is operating, so EBITDA is of limited relevance. FY2021 dividends = HK10c interim + HK10c special + HK15c final; FY2022 = HK10c interim + HK10c final; FY2023 = HK15c interim + HK10c final; FY2024 = HK20c final (no interim); FY2025 = HK5c interim, no final. All dividends paid out of the share premium account.

Margins and growth

Revenue (total income) CAGR FY2021–FY2025: ~2.9%. Net profit moved from RMB1,179.3m to a RMB559.8m loss over the same period.

Half-year bridge

Implied H2 2025: total income RMB1,371.0m, net loss RMB775.8m. Trailing-twelve-month (H2 2025 + H1 2026) total income RMB2,340.2m and net loss RMB763.8m. Sources: H1 2025 and H1 2026 announcements; FY2025 announcement.

Balance sheet

Notes: Short/long split uses the repayment-schedule disclosure for borrowings plus notes classified by maturity date. Goodwill: none disclosed. Working capital: not presented — the group uses an unclassified (liquidity-ordered) balance sheet. Net debt here includes consolidated trust payables, which are funded by trust investors and secured against trust loan assets rather than being general corporate borrowings.

Mid-2026 snapshot (30 Jun 2026, unaudited, RMB m): total assets 5,457.5; cash 1,658.3; restricted cash 501.1; loans to customers 1,316.2 (of which FVTPL 882.9, with 678.4 overdue); guarantee receivables 345.8; deferred tax assets 905.9; borrowings 321.5 (trust payables only 23.5); notes payable 205.0; total debt 526.5; net cash 1,131.8; guarantee liabilities 369.5; total liabilities 1,509.7; equity 3,947.8; gearing 27.7%; company-defined debt-to-equity 0.2x.

Cash flow

Notes: Annual capex is not separately disclosed in the results announcements (H1 2025: RMB8.8m; H1 2026: RMB3.8m PP&E payments); free cash flow is therefore not computed. For a balance-sheet lender, operating cash flow is dominated by loan origination/repayment on direct and trust structures and is not a measure of earnings quality: FY2025's RMB2.57bn inflow reflects shrinking trust lending, not profitability. FY2022 buyback HK$2.80m converted at ~0.9. H1 2026: operating inflow RMB2,691.2m; investing inflow RMB132.9m (including RMB127.7m BPG deposit refund); financing outflow RMB2,550.4m (trust plan run-off).

Ratios

Notes: ROE and ROA on average balances except FY2021 (closing balances). ROIC, current ratio and cash conversion cycle are not meaningful for this business model (unclassified balance sheet; no inventory/payables cycle) and are reported as not applicable. FY2025 net debt/EBITDA not meaningful (negative EBITDA).

Commentary on trends, inflections and drivers

FY2021 — peak profitability on legacy pricing. Total income rose 34.4% to RMB3,458m and net profit reached RMB1,179m, a turnaround from a RMB870m FY2020 loss. Profit was flattered by RMB455.6m of guarantee gains (as guarantee ECLs released after COVID-era over-provisioning; guarantee liability ECL remeasurement was a RMB376.6m credit) and by pricing that still reached 36% APR. Operating margin of 43.8% was unsustainable.

FY2022 — regulatory repricing. Management migrated the book toward loans at or below 24% APR to align with regulatory pricing guidance; operating profit halved to RMB695m despite origination rising 28.2% to RMB52.2bn. Pure facilitation (asset-light) jumped from 3.5% to 14.6% of origination and partner count rose to 92. Trust lending was cut sharply, producing a RMB3.0bn operating cash inflow and allowing repayment of the US$85m notes.

FY2023 — volume record, deteriorating quality. Origination hit RMB75.2bn (+44.2%) and facilitation fees rose 43.3%, but credit impairment almost tripled to RMB345m and M1–M3 delinquency rose from 3.53% (Q4 2022) to 5.07% (Q4 2023). Net profit fell 14.8% to RMB454m. Credit-enhanced facilitation reached 67.3% of volume — the structural concentration that later proved costly.

FY2024 — quality reset at lower volume. Origination fell 25.9% to RMB55.8bn as management tightened risk; delinquency improved (M3+ 3.02% in Q4 2024, first-payment delinquency 0.58%), and income rose 10.1% on higher-yielding direct/trust balances and a doubling of technology/platform fees. Net profit +5.3% to RMB478m; final dividend raised to HK20c. The share price rose strongly (reported ~80% gain in early 2025).

FY2025 — the break. H1 2025 was strong (net profit +79.5%), but the NFRA rules effective 1 October 2025 cut the maximum APR from ~36% to 24%, prompted banks to prune high-pricing partners, and tightened sector liquidity. Borrowers reliant on refinancing became delinquent: M1–M3 jumped to 6.89% and M3+ to 5.99% in Q4 2025. The fair-value loss on loans rose 75.5% to RMB1,718.5m and guarantee activity flipped to a RMB513.1m loss (guarantee liabilities ECL remeasurement RMB474.5m; net payouts RMB3,373.2m). H2 2025 net loss of ~RMB776m produced a full-year loss of RMB559.8m. Partially offsetting, technology/platform fees rose 155% to RMB577.2m. Equity fell RMB655m.

H1 2026 — managed contraction. Origination collapsed to RMB6.06bn (−84.1%), with trust and pure facilitation effectively ceasing; credit-enhanced facilitation is 93.0% of what remains. Total income −61.2%; operating expenses −57.7%; headcount down to 580. The group returned to a marginal RMB12.0m profit as credit costs fell with the book. New-vintage quality improved (first-payment delinquency 0.44% in Q2 2026), but the stock M3+ ratio climbed to 8.64% as the denominator shrank. The balance sheet is now net-cash (RMB1.13bn), with equity of RMB3.95bn; the binding constraint has shifted from capital to funding-partner access and permissible pricing.

Management guidance

No numerical guidance. Management's outlook (H1 2026) emphasises prudence: continue optimising mainland consumer finance for high-quality customers, deepen Hong Kong and Southeast Asia, advance AI applications (model coordination, data governance, engineering platforms in H2 2026), maintain regulatory alignment and cautiously evaluate investments.

Consensus expectations

None available (no sell-side coverage identified).

Bull case

1. Deep value with downside cushion: the stock trades at ~0.10x book and below net cash (RMB1.13bn net cash vs ~RMB0.41bn market cap); even heavy haircuts to the DTA (RMB905.9m) and remaining loans leave tangible value well above market cap.

2. Clean new vintages + capital-light fee growth: FPD of 0.44% in Q2 2026 and technology/platform fees of RMB437.0m in H1 2026 (+103%) suggest a path to sustainable, if smaller, profitability once legacy delinquent loans run off.

3. Consolidation beneficiary: if VCREDIT remains on major banks' whitelists while smaller platforms exit, origination can rebuild from a low base (H1 2026 run-rate ~RMB12bn annualised vs RMB58bn in 2025) with a much leaner cost base (580 staff).

Bear case

1. Structural impairment of the core model: credit-enhanced facilitation (93% of volume) is precisely what the 24% all-in cap and guarantee-cost transparency target; normalised returns may be permanently lower than the 11–15% ROE of FY2022–FY2024.

2. Legacy asset quality and DTA risk: stock M3+ at 8.64% and RMB678.4m of overdue FVTPL loans could produce further fair-value and guarantee losses; failure to return to taxable profit would force DTA write-downs (23% of equity).

3. No credible diversification and control overhang: the BPG failure, a loss-making Hong Kong unit and a nascent Indonesian business offer little offset, while a 50.68% controlling shareholder and minimal free float limit catalysts and could enable a low-premium take-private.

Key catalysts and monitorables (next 12 months)

• FY2026 annual results (expected late March 2027): H2 2026 origination run-rate, return (or not) to dividends.

• Funding partner count and whitelist inclusion at major banks (not disclosed since mid-2025).

• Quarterly delinquency: M3+ trajectory as the legacy book runs off; FPD stability below ~0.6%.

• Guarantee liabilities vs receivables balance and payouts.

• Technology/platform service fee sustainability and disclosure of counterparties.

• Hong Kong segment path to breakeven (impairments vs income) and refinancing of HK$198m notes due 2026.

• Indonesia first disclosed volumes and OJK compliance.

• Any capital-return action (buyback, special dividend) or controlling-shareholder corporate action.

• Further NFRA guidance on credit-enhancement providers and comprehensive cost disclosure.

• DTA assessment in FY2026 audit.

Analyst verdict

VCREDIT is a case study in regulatory model risk. For a decade the group monetised near-prime Chinese borrowers through a guarantee-backed facilitation model priced up to 36% APR, producing strong but volatile earnings (RMB1.18bn net profit in FY2021; RMB454–532m in FY2022–FY2024) and steady dividends. The NFRA loan-facilitation rules effective 1 October 2025 struck directly at that model: the all-in cost cap of 24%, bank whitelisting and cost transparency triggered a borrower refinancing squeeze, a spike in delinquencies (Q4 2025 M3+ 5.99%, rising to 8.64% by Q2 2026), a RMB513m guarantee loss and a RMB560m FY2025 net loss. Management's response — slashing origination 84%, running off the trust book, cutting headcount by over a quarter, and leaning on technology/platform fees — has stabilised the P&L at breakeven (H1 2026 net profit RMB12.0m) and left a net-cash balance sheet with RMB3.95bn of book equity.

The equity market prices VCREDIT as a liquidating or impaired franchise at ~0.1x book and a negative enterprise value. That discount is not irrational: the remaining business is 93% concentrated in the very structure regulators are squeezing; legacy loans are still deteriorating; RMB906m of deferred tax assets rely on future profits; the diversification strategy has largely failed (BPG) or is sub-scale (Hong Kong, Indonesia); and control rests with a single 50.68% shareholder, limiting minority leverage over capital allocation.

Our synthesis: VCREDIT is no longer a growth fintech but a special-situation balance-sheet story. Upside requires either (a) evidence that whitelisted, ≤24% APR lending can be rebuilt profitably at scale — watch funding partner disclosures and H2 2026 origination — or (b) capital return of surplus cash to minorities. Absent either, the discount is likely to persist. We regard the risk profile as high, the information quality as moderate, and the key swing factors as regulatory treatment of credit enhancement and the controlling shareholder's intentions.